This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Pfizer Corporation. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Shenping Liu: Innovator in Pharmaceutical Research
Introduction
Shenping Liu is a notable inventor based in Waterford, CT (US). He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target specific health conditions.
Latest Patents
Shenping Liu holds a patent for BCKDK inhibitors and/or degraders. This patent describes compounds of Formula I, which are utilized as branched-chain alpha keto acid dehydrogenase kinase inhibitors and/or degraders. These compounds have potential applications in treating various health issues, including diabetes, kidney disease, NASH, and heart failure.
Career Highlights
Shenping Liu is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work focuses on innovative solutions that address critical health challenges.
Collaborations
Shenping Liu collaborates with Leanne Marie Buzon, contributing to advancements in their field through shared expertise and research efforts.
Conclusion
Shenping Liu's work exemplifies the impact of innovation in the pharmaceutical industry, showcasing his commitment to improving health outcomes through targeted research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile